Internal correspondence and Senate submissions show the CSIRO is running out of money and may lose its position as a leading research agency.
Semiconductor manufacturers are spending tens of billions of dollars to build advanced factories in Arizona and Texas. They’re being cheered on by the federal government, which has chipped in billions ...
Radioligand therapies gained momentum in 2025 with FDA’s Pluvicto approval. Here’s why 2026 could drive growth and adoption.
MetaVia Inc. , a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced a strong global intellectual property portfolio supporting lead asset DA-1726, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results